Neola Medical: Approved clinical study in Sweden - Redeye

Redeye comments on Neola Medical’s approved clinical study in Sweden, which is expected to run for approximately four months and serve as a preparatory step for the upcoming US clinical trial. We also look ahead to the company’s Q4 2024 report, set for release tomorrow.

Länk till analysen i sin helhet: https://www.redeye.se/research/1074608/neola-medical-approved-clinical-study-in-sweden?utm_source=finwire&utm_medium=RSS